SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-24-255127
Filing Date
2024-11-12
Accepted
2024-11-12 07:11:53
Documents
15
Period of Report
2024-11-12
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d793963d8k.htm   iXBRL 8-K 25462
2 EX-99.1 d793963dex991.htm EX-99.1 90498
6 GRAPHIC g793963g38n48.jpg GRAPHIC 9446
  Complete submission text file 0001193125-24-255127.txt   262912

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA iobt-20241112.xsd EX-101.SCH 2858
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE iobt-20241112_lab.xml EX-101.LAB 17912
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE iobt-20241112_pre.xml EX-101.PRE 11240
17 EXTRACTED XBRL INSTANCE DOCUMENT d793963d8k_htm.xml XML 3616
Mailing Address OLE MAALOES VEH 3 COPENHAGEN G7 2200
Business Address OLE MAALOES VEH 3 COPENHAGEN G7 2200 4570702980
IO Biotech, Inc. (Filer) CIK: 0001865494 (see all company filings)

IRS No.: 870909276 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-41008 | Film No.: 241443240
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)